Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Soonchunhyang University Bucheon Hospital, |
RCV000490489 | SCV000267311 | likely pathogenic | Fanconi anemia complementation group I | 2016-03-18 | criteria provided, single submitter | reference population | |
Baylor Genetics | RCV000490489 | SCV004197226 | pathogenic | Fanconi anemia complementation group I | 2022-12-23 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003522949 | SCV004277271 | likely pathogenic | Fanconi anemia | 2023-05-14 | criteria provided, single submitter | clinical testing | This sequence change affects an acceptor splice site in intron 3 of the FANCI gene. RNA analysis indicates that disruption of this splice site induces altered splicing and may result in an absent or disrupted protein product. This variant is present in population databases (rs762128147, gnomAD 0.01%). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Studies have shown that disruption of this splice site results in a single nucleotide insertion and introduces a premature termination codon (PMID: 30792206). The resulting mRNA is expected to undergo nonsense-mediated decay. ClinVar contains an entry for this variant (Variation ID: 225355). Disruption of this splice site has been observed in individual(s) with fanconi anemia (PMID: 30792206). |